Colorectal cancer (CRC) is the leading cause of cancer deaths around the world. It is
necessary to identify patients with poor prognosis or with high risk for recurrence so that we …

Post-operative inflammation in cancer patients can be modulated by drugs and diets, but
evidence on its prognostic role, which would be crucial for personalized treatment and …

Increasing evidence indicates cancer-related inflammatory biomarkers show great promise
for predicting the outcome of cancer patients. The lymphocyte-monocyte ratio (LMR) was …

BACKGROUND Colorectal cancer is the third most common malignancy worldwide.
Therefore, it is critically important to identify new useful markers that can be easily obtained …

Although numerous studies have highlighted the prognostic values of various inflammation-
related markers, clinical significance remains to be elucidated. The prognostic values of …

Purpose Although neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR),
monocyte count, and Glasgow prognostic score (GPS) are well-known prognostic markers in …

AIM: To test the correlation between lymphocyte-to-monocyte ratio (LMR) and survival after
radiofrequency ablation (RFA) for colorectal liver metastasis (CLMs). METHODS: From July …

A correlation between the lymphocyte‑to‑monocyte ratio (LMR) and the survival of patients
with hematological malignancies has been reported previously. However, there have been …

Background Lymphocyte to monocyte ratio (LMR) was recently reported as a prognostic
factor of pancreatic cancer (PC). However, the prognostic role of LMR in PC remains …

Background The preoperative systemic inflammation has been reported to predict tumor
recurrence and survival in various cancers, including colorectal liver metastases (CRLM) …